Advanced Heart Failure and Transplant Cardiology · Greensboro, NC
NPI
1245293505
Since 2006
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1200 N Elm St Ste 1982
Greensboro, NC, 27401
Phone (336) 832-9292
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,393 services
Medicare patients, 2024
625
Average age 75
Drug cost, 2024
$10.6M
8,877 prescriptions
Company payments, 2025
$323K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Bensimhon was code 93306 (echocardiography (tte/tee)), 285 times for 285 patients. In total Daniel R Bensimhon billed 1,393 services in 46 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 285 | 285 | $49.40 | $14K |
| 93010 Electrocardiogram | Facility | 180 | 150 | $5.32 | $958 |
| 99233 Hospital E&M - Subsequent | Facility | 118 | 47 | $88.08 | $10K |
| 99214 Office E&M - Established | Facility | 98 | 78 | $65.95 | $6,463 |
| 99291 Critical Care E&M | Facility | 91 | 28 | $155.69 | $14K |
| 93750 External Electrocardiographic Monitoring | Facility | 91 | 14 | $28.84 | $2,625 |
| 99215 Office E&M - Established | Facility | 58 | 26 | $103.10 | $5,980 |
| 76376 CT Scan | Facility | 54 | 54 | $6.58 | $356 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 31 | $58.39 | $2,920 |
| 99214 Office E&M - Established | Office | 33 | 22 | $95.60 | $3,155 |
| 93356 Echocardiography (TTE/TEE) | Facility | 32 | 32 | $7.47 | $239 |
| 99223 Hospital E&M - Initial | Facility | 24 | 21 | $120.71 | $2,897 |
| 93289 External Electrocardiographic Monitoring | Facility | 23 | 21 | $24.25 | $558 |
| 93325 Echocardiography (TTE/TEE) | Facility | 20 | 20 | $2.31 | $46.12 |
| 93308 Echocardiography (TTE/TEE) | Facility | 17 | 17 | $18.52 | $315 |
By year: 2022 $125K for 1,694 services; 2023 $107K for 1,625 services; 2024 $81K for 1,393 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Bensimhon prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 872 prescriptions and refills. In total Daniel R Bensimhon wrote 8,877 Medicare prescriptions that cost $10.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 872 | 1,282 | 167 | $847K |
| Spironolactone Generic | 764 | 1,786 | 222 | $4,622 |
| Eliquis Apixaban | 613 | 797 | 109 | $454K |
| Carvedilol Generic | 599 | 1,318 | 161 | $5,219 |
| Jardiance Empagliflozin | 494 | 775 | 113 | $452K |
| Furosemide Generic | 448 | 878 | 132 | $1,701 |
| Farxiga Dapagliflozin Propanediol | 406 | 640 | 86 | $356K |
| Losartan Potassium Generic | 347 | 847 | 115 | $3,162 |
| Atorvastatin Calcium Generic | 330 | 788 | 90 | $4,455 |
| Torsemide Generic | 287 | 559 | 96 | $9,267 |
| Metoprolol Succinate Generic | 247 | 564 | 77 | $3,239 |
| Amiodarone Hcl Generic | 227 | 437 | 64 | $2,915 |
| Potassium Chloride Generic | 226 | 404 | 73 | $5,800 |
| Rosuvastatin Calcium Generic | 200 | 467 | 52 | $3,136 |
| Warfarin Sodium Generic | 170 | 305 | 40 | $1,606 |
Brand drugs: - claims; generic drugs: 5,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Bensimhon $323K ($323K in general payments such as food, travel and fees) from 17 companies. The largest payer was Ge Healthcare with $168K.
| Company | Payments | Amount |
|---|---|---|
| Ge Healthcare GEHC | 8 | $168K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 26 | $34K |
| Sensible Medical Innovations Inc | 1 | $33K |
| Merck Sharp & Dohme LLC MRK | 20 | $25K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $19K |
| Actelion Pharmaceuticals US, Inc. JNJ | 15 | $15K |
| Scpharmaceuticals Inc. SCPH | 8 | $10K |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $6,774 |
| BridgeBio Pharma, Inc. BBIO | 6 | $6,175 |
| Lilly USA, LLC LLY | 3 | $3,900 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.